Literature DB >> 3551993

Beta 2-microglobulin, different fragments and polymers thereof in synovial amyloid in long-term hemodialysis.

R P Linke, H Hampl, S Bartel-Schwarze, M Eulitz.   

Abstract

Amyloid deposits of a patient with long-term hemodialysis were immunohistochemically identified as beta 2-microglobulin (beta 2m)-derived. Amyloid proteins were isolated from fibril concentrates from the synovia by HPLC permeation chromatography. Further analysis included dot immunoassay, immunodiffusion, SDS-polyacrylamide gel electrophoresis and Western blotting. Proteins with molecular masses of 8.5, 12, 17 and 24 kDa as well as polymers of higher molecular mass were detected. Neither the 24-kDa dimer nor the higher polymers could be significantly reduced by disulfide reagents. The N-terminal amino-acid sequence analyses of the two major proteins of 12 and 24 kDa showed the same two sequences each: one commencing with position 1 and the other with position 7 of beta 2m. These results suggest that limited proteolysis and polymer formation independent from interchain disulfide bridging, both play a role in the genesis of beta 2m-derived amyloid in the synovia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3551993     DOI: 10.1515/bchm3.1987.368.1.137

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  15 in total

1.  The solution structure of human beta2-microglobulin reveals the prodromes of its amyloid transition.

Authors:  Giuliana Verdone; Alessandra Corazza; Paolo Viglino; Fabio Pettirossi; Sofia Giorgetti; Palma Mangione; Alessia Andreola; Monica Stoppini; Vittorio Bellotti; Gennaro Esposito
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

2.  Immunohistological characterisation of amyloid deposits in renal biopsy specimens.

Authors:  R J Fitzmaurice; C Bartley; J McClure; P Ackrill
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

3.  Structural modifications of human beta 2 microglobulin treated with oxygen-derived radicals.

Authors:  C Capeillere-Blandin; T Delaveau; B Descamps-Latscha
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

4.  Spinal cord compression in renal osteodystrophy.

Authors:  J D Macfarlane; A Minhas; K S Han; M Boekhout
Journal:  Eur Spine J       Date:  1995       Impact factor: 3.134

Review 5.  beta 2-Microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

6.  Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis.

Authors:  Sofia Giorgetti; Monica Stoppini; Glenys A Tennent; Annalisa Relini; Loredana Marchese; Sara Raimondi; Maria Monti; Sara Marini; Ole Østergaard; Niels H H Heegaard; Piero Pucci; Gennaro Esposito; Giampaolo Merlini; Vittorio Bellotti
Journal:  Protein Sci       Date:  2007-02       Impact factor: 6.725

7.  Excess-substrate inhibition in enzymology and high-dose inhibition in pharmacology: a reinterpretation [corrected].

Authors:  P W Kühl
Journal:  Biochem J       Date:  1994-02-15       Impact factor: 3.857

Review 8.  Pathological fractures and lytic bone lesion of the femoral neck associated with beta 2-microglobulin amyloid deposition in long-term dialysis patients.

Authors:  G F Scheumann; M Holch; M L Nerlich; A Brandis; H Ostertag; H Tscherne
Journal:  Arch Orthop Trauma Surg       Date:  1991       Impact factor: 3.067

9.  [Serum level and organ deposits of beta 2-microglobulin in dialysis patients].

Authors:  G Stein; A Schneider; H Toss; R Linke; K Schaefer; E Ritz
Journal:  Klin Wochenschr       Date:  1990-11-16

10.  Molecular variants of beta 2-microglobulin in renal insufficiency.

Authors:  C Vincent; L Dennoroy; J P Revillard
Journal:  Biochem J       Date:  1994-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.